Evaluation of some clotting factors ( F I , FVII , FVIII and FIX) and estradiol hormone deficiency in menopausal women
DOI:
https://doi.org/10.36320/ajb/v8.i1.8022Keywords:
estradiol hormone , clotting factors , menopauseAbstract
Women are complained from several physiological and biochemical disturbances when they become aged and loss adequate amount of estradiol hormone secreted from ovarian follicles . The present study conduct to evaluate the concentration of some available clotting factors and feminizing hormone ( estradiol hormone) in menopausal women . A total number of participants postmenopausal women was sixty (60) women and their ages were 50 to 69 years old and fifteen (15) women their ages premenopausal women ( control group) that they have normal menstruation cycle and whose ages ranged between 20 – 25 years old. The aging women ( menopause ) were subdivided according to their ages periods in to four groups , the first group ( 50 – 54 years ) , second group ( 55 – 59years ) , third group ( 60- 64 years) , and fourth group (65 –69 years ).Downloads
References
- (1) Santoro , N . and Randolph , J . F. ( 2011 ). Reproductive hormones and the menopause transition Obstetrics Gynecol. Clin. North America , 38 : 455- 466. DOI: https://doi.org/10.1016/j.ogc.2011.05.004
- (2) Ylikorkala , O . (1992). The prostaglandin / thromboxane balance . : high – light safety aspects of hormone replacement therapy . Novo Nordisk International . Symposium .
- (3) Lowe ,G.D. , Rumley , A. , woodward , M. , Morrison , C. E. , and Lane , D.A. ( 1997). Epidemiology of coagulation factors , inhibitors and activation markers : The Third Glasgow MONICA Survey . I. Illustrative reference ranges by age , sex and hormone use . British J. Hematol., , 97 : 775 -784 DOI: https://doi.org/10.1046/j.1365-2141.1997.1222936.x
- (4 ) Cowman ,J. , Dunne , E. , and Kenny , D. ( 2015 ) . Age related changes in platelet function are more profound in women than in men . Sci. Rep. , 5 :12235 . DOI: https://doi.org/10.1038/srep12235
- (5) Daniel, W.W. ( 1999) . Biostatistics : a foundation for analysis in the health science . 7ed . John Wily . Philadelphia .pp 8 .
- (6) Bouman , A ., Haneman , M . and Fass , M. ( 2005 ) . Sex hormone and the immune response in human . Human Reprod. , Update , 11 (4) : 411- 423 . DOI: https://doi.org/10.1093/humupd/dmi008
- (7) Arslan , M . ,T. , Ozcetin , M ., Ozyurek , R ., and Kavakli , K . ( 2011 ) . Rate of abnormal coagulation test result in patients with congenital heart disease . J . Contemporary Med ., 1 (1) : 6- 11 .
- (8) Pasa , S , Altintas , A., Tumer , C., Demircin, M.,Cil, T., Bayan , K., Danis , R., Tuzun, Y., and Baheci , M . (2010) . Prothrombin time , activated thromboplastin time , fibrinogen , D- dimer levels, and vonwillebrand factor of patients with Sheehans syndrome and the effect of hormone replacement therapy on these factors Intrnational J. Hematol . and Oncology , 4 (20) : 212- 219 .
- (9) Kamal ,A.H ., Tefferi , A., and Pruthi , R . K . (2007 ).How to interpret and pursue an abnormal prothrombin time , activated partial thromboplastin time , and bleeding time in adults .J.Mayo. Clin. Proc.,82 (7) :864- 873. DOI: https://doi.org/10.4065/82.7.864
- (10) Turgeon , M. L. ( 1999) . Clinical Hematology , Theory and Procedures 3rd ed. Lippincott Williams and Wilkins , Philadelphia , 398-422.
- (11) –Kofoed ,S.C.,Wittrup ,H.H.,Sillesen ,H., and Nodestgaard,B.G.(2018).Fibrnogen predicts ischemic strok and advanced atherosclerosis but not rupture prone carotid plagues.Copnhangen City Euro-Heart J.,24 :567-576.
- (12) Cushman , M. , Meilahan , E., N . , Psaty , B .M. , Kuller , L. H. , Dobs , A.S ., and Tracy , R.P . ( 1999). Hormone replacement therapy , inflammation and hemostasis in elderly women . Areriosclerosis Thrombosis Vascular Biology , 19 : 893- 899 . DOI: https://doi.org/10.1161/01.ATV.19.4.893
- (13) Mead , T. W. , Ruddok , V. , Stirling , Y , Chakrabarti , R. , and Miller , G. J. ( 1993) . Fibrinolytic activities , clotting factors , and long term incidence of ischemic heart disease in the Northwick Park Heart Study . Lancet , 342 : 1076- 1079 . DOI: https://doi.org/10.1016/0140-6736(93)92062-X
- (14) Vigen, C. , Hodis , H. n., Chandler , W. L. , Lobo , R. A. , and Mack , W. J. ( 2007). Postmenopausal oral estrogen therapy affects hemostatic factors , but does not account for reduction in progression of subclinical atherosclerosis ..J. Thrombosis Hemostasis , 5 :1201 – 1208 . DOI: https://doi.org/10.1111/j.1538-7836.2007.02547.x
- (15) Lip , G. Y ., Blann , A.D. , Jones , A.F. , and Beevers , D.G. (1997). Effects of hormone- replacement therapy on for prevention of atherosclerosis American Heart J., : 143
- (16) Salomaa , V., Rasi , V., and Pekkaanen ,J . ( 1995) . Association of hormone replacement therapy with hemostatic and other risk factors : the FINRISK hemostasis study , atheriosclerosis thrombosisvascular Biological , 15: 1549- 1555. DOI: https://doi.org/10.1161/01.ATV.15.10.1549
- (17) Markmann , P ., Toubro , S., and Astrup , A. ( 1998). Sustained improvement in blood lipid , coagulation , and fibrinolysis after major weight loss in Obese subjects . J. Clin . Nutias , 52 : 329- 333. DOI: https://doi.org/10.1038/sj.ejcn.1600558
(18) Devalk, D .G.W. , Stehouwer , D.A. , Emeis . J . , Nicolaas , M.K. , and Netelebos , C. ( 2000) . Unopposed estrogen increase total plasma FVII , but not active FVII . Thromb. Heamostasis , 84 : 968 -972 DOI: https://doi.org/10.1055/s-0037-1614157
- (19) Kofoed , S.C ., Wittrup, H.H , Sillesen, H. , and Nodestgaard , B. G. ( 2018). Fibrinogen predicts ischemic stroke and advanced atherosclerosis but not rupture prone carotid plaqus .Copenhagen City . Euro-Heart J. , 24 : 567- 576. DOI: https://doi.org/10.1016/S0195-668X(02)00467-0
- (20) Wright , D ., Poller , L., Thombson , J. M . , and Sidebotham , A . ( 1997). The effect of hormone replacement therapy on the age – related rise of factor VIIc , and its activity stat . Thrombosis Res., 85 : 455 – 464 . DOI: https://doi.org/10.1016/S0049-3848(97)00035-2
- (21) Kyrle , P.A. , Minar, E ., and Hirschl, M . ( 2000) . High plasma level of FVIII and the risk of recurrent venous thromboembolism . N. Engl. J . Med., 343 :457- 462 . DOI: https://doi.org/10.1056/NEJM200008173430702
- (22) Odonnell, J. , Mumford , A.D. , and Manning , R.A. ( 2000). Elevation of FVIII : C in venous thromboembolism is persistent and in dependent of the acute phase response . Thrombosis Hemostasis , 83 (1) :10- 13. DOI: https://doi.org/10.1055/s-0037-1613748
- (23) Palareti , G., Legnani, C., and Frascro ,M. ( 1995) . Factor VIII :C levels during oral anticoagulation and after its withdrawal .Thrombosis Hemostasis , 74 : 1609- 1610. DOI: https://doi.org/10.1055/s-0038-1649992
- (24) Gonzalez , O.A .J. , Medina , J. M., and Martin , L. ( 1999). The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin . Blood coagulation Fibrinolysis , 10: 303 – 307 DOI: https://doi.org/10.1097/00001721-199907000-00013
- (25) Sowers, M.R. , Mattewaas , K.A. , Jannaunsch , M. and Randloph , J. F. ( 2005 ) . Hemostaticfactors and estrogen during the menopausal transition . Clin. Endocrinol. Metab. , 90 ( 11) : 5942- 5948 . DOI: https://doi.org/10.1210/jc.2005-0591
- (26) Bucciarelli , P . and Mannucci , P. M. ( 2009) . The hemostatic system through aging and menopause . Climacteric , 12 (1) : 47- 51 . DOI: https://doi.org/10.1080/13697130903006365
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Reem Abdul – Rheem Mardan Al- Saadi
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
